Know Cancer

or
forgot password
  • cancer clinical trials in zion, IL

  • Nutrition Intervention in Treating Women With Breast Cancer
    Midwestern Regional Medical Center
    Zion, Illinois 60099
    Breast Cancer
    Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer
    Investigational Site
    Zion, Illinois 60099
    Breast Neoplasms, Neoplasms
    Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer
    Cancer Treatment Centers of America (CTCA-Midwestern)
    Zion, Illinois 60099
    Adenocarcinoma of the Ovary
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Midwestern Regional Medical Center
    Zion, Illinois 60099
    Advanced Prostate Cancer, Prostatic Neoplasms
    Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury
    Cancer Treatment Centers of America at Midwestern Regional Medical Center
    Zion, Illinois 60099
    Cancer, Hepatic Injury
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Midwestern Regional Medical Center
    Zion, Illinois 60099
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
    Midwestern Regional Medical Center
    Zion, Illinois 60099
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
    Midwestern Regional Medical Center
    Zion, Illinois 60099
    Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Neuroblastoma, Ovarian Cancer, Sarcoma, Testicular Germ Cell Tumor
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Midwestern Regional Medical Center
    Zion, Illinois 60099
    Non Small Cell Lung Carcinoma
    Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors
    CTCA @ Midwestern Regional Medical Center
    Zion, Illinois 60099
    Cancer
    Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
    Cancer Treatment Centers of America (CTCA-Midwestern)
    Zion, Illinois 60099
    Ovarian Cancer
    Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
    Midwestern Regional Medical Center
    Zion, Illinois 60099
    Non-Small Cell Lung Cancer
    A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
    Cancer Treatment Centers of America at Midwestern Regional Medical Center
    Zion, Illinois 60099
    Breast Cancer
    Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy
    Midwestern Regional Medical Center
    Zion, Illinois 60099
    Thrombocytopenia, Neoplasm, Cancer
    Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
    Cancer Treatment Centers of America
    Zion, Illinois 60099
    Locally Recurrent or Metastatic Breast Cancer